Companies in the biopharma sector developing innovative solutions and technologies.
Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Origin Endoscopy offers medical products to control the hemostatic effects of gastrointestinal bleeding during endoscopy procedures.
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
Caristo Diagnostics is a biotech company that provides diagnostic platforms for heart diseases, stroke, and diabetes.
Concerto Biosciences measures, maps, and utilizes microbes to create therapies and products for agriculture and human health industries.
Mirai Bio provides access to end-to-end development capabilities with innovation at every step.
Peptinovo develops novel nanoparticles targeting anti-cancer drugs to tumors for improved therapeutic outcomes and reduced side effects.
LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
Lucidome Bio develops a simple vaccine to reduce ruminant methane emissions while solving an acute climate change issue.
Metabolics Pharma is a biotechnology company that offers pharmaceutical companies.
PictorLabs offers virtual staining technology using proprietary models powered by artificial intelligence.
Vironexis has the potential to transform immunotherapy and the way cancer is treated in the future.
PhoreMost is a new-model drug discovery company based in Cambridge, UK.
Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.
KuriBio builds a nanotechnology platform for therapeutic applications in oncology and beyond.
OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.
HDAC6, small molecule, peripheral neuropathy, cardiometabolic, pharmaceuticals, biotech, biopharma, life science
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators.
ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.
Optimvia is a biopharmaceutical company that specializes in engineering proteins with tailored functions to combat disease.
Photonpharma develops an autologous cell therapy platform for the treatment of solid tumor cancers.
Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.
The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.
Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked